BT202110: IHCP clarifies drugs carved-out of managed care and PA criteria
Summary
IHCP clarifies that 8 classes of high-cost specialty drugs (including CAR-T therapies, gene therapies, cystic fibrosis agents, and others) are carved out of managed care and processed through fee-for-service, with specific prior authorization criteria and billing codes for CAR-T treatments.
Get alerts when payers change rules like this one
We check Indiana Medicaid (IHCP) and other payers every day and email you when a change matches your specialty and state.